재고 위치

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

Abiraterone-5,6-Epoxide

● Under Development

카탈로그 번호:	VL830013
CAS 번호:	N/A
분자식:	C24H31NO2
분자량:	365.52 g/mol

무엇을 도와드

RFQ 목록에 추가

에 대한 추가 정보 Abiraterone-5 | 6-Epoxide

모약물

Abiraterone

IUPAC명

(3S, 6aS, 6bS, 9aS, 11aS, 11bR)-9a, 11b-dimethyl-9-(pyridin-3-yl)-1, 2, 3, 4, 5a, 6, 6a, 6b, 7, 9a, 10, 11, 11a, 11b-tetradecahydrocyclopenta[1, 2]phenanthro[8a, 9-b]oxiren-3-ol

약전 동의어

N/A

SMILES

O[C@H](C1)CC[C@]2(C)[C@@]3([H])CC[C@@](C(C4=CC=CN=C4)=CC5)(C)[C@]5([H])[C@]3([H])CC6C21O6

설명

Abiraterone-5,6-Epoxide or (3S,6aS,6bS,9aS,11aS,11bR)-9a,11b-dimethyl-9-(pyridin-3-yl)-1,2,3,4,5a,6,6a,6b,7,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-3-ol, is an antiandrogen class and it is a used in the treatment a certain type of prostate cancer.

References

Goldberg, Tamara, and Evangelina Berrios-Colon. “Abiraterone (Zytiga), a Novel Agent for the Management of Castration-Resistant Prostate Cancer.” Pharmacy and Therapeutics, vol. 38, no. 1, 1 Jan. 2013, pp. 23–26, www.ncbi.nlm.nih.gov/pmc/articles/PMC3628169/.

InChI

InChI=1S/C24H31NO2/c1-22-9-8-20-17(19(22)6-5-18(22)15-4-3-11-25-14-15)12-21-24(27-21)13-16(26)7-10-23(20,24)2/h3-5,11,14,16-17,19-21,26H,6-10,12-13H2,1-2H3/t16-,17-,19-,20-,21?,22+,23+,24?/m0/s1